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Abstract
Inferring molecular networks is a central challenge in computational biology. However, it has 
remained unclear whether causal, rather than merely correlational, relationships can be effectively 
inferred in complex biological settings. Here we describe the HPN-DREAM network inference 
challenge that focused on learning causal influences in signaling networks. We used 
phosphoprotein data from cancer cell lines as well as in silico data from a nonlinear dynamical 
model. Using the phosphoprotein data, we scored more than 2,000 networks submitted by 
challenge participants. The networks spanned 32 biological contexts and were scored in terms of 
causal validity with respect to unseen interventional data. A number of approaches were effective 
and incorporating known biology was generally advantageous. Additional sub-challenges 
considered time-course prediction and visualization. Our results constitute the most 
comprehensive assessment of causal network inference in a mammalian setting carried out to date 
and suggest that learning causal relationships may be feasible in complex settings such as disease 
states. Furthermore, our scoring approach provides a practical way to empirically assess the causal 
validity of inferred molecular networks.
Introduction
Molecular networks are central to biological function and the data-driven learning of 
regulatory connections in molecular networks has long been a key topic in computational 
biology1–6. An emerging notion is that networks describing a certain biological process, for 
example signal transduction or gene regulation, may depend on biological context, such as 
cell type, tissue type, or disease state7,8. This has motivated efforts to elucidate networks that 
are specific to such contexts9–14. In disease settings, networks specific to disease context 
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could improve understanding of the underlying biology and potentially be exploited to 
inform rational therapeutic interventions.
In this study, we considered inference of causal molecular networks, focusing specifically on 
signaling downstream of receptor tyrosine kinases. We define edges in causal molecular 
networks (“causal edges”) as directed links between nodes in which inhibition of the parent 
node can lead to a change in abundance of the child node (Fig. 1a), either by direct 
interaction or via unmeasured intermediate nodes (Fig. 1b). Such edges may be specific to 
biological context (Fig. 1c). The notion of a causal link is fundamentally distinct from a 
correlational one (Fig. 1d). Causal network inference is profoundly challenging15,16 and 
many methods for inferring regulatory networks connect together correlated, or mutually 
dependent, nodes that may not have any causal relationship. Some approaches (e.g. causal 
directed acyclic graphs17–19) are intended to infer causal relationships, but their success can 
only be guaranteed under very strong assumptions15,20 that are almost certainly violated in 
biological settings. This is due to many limitations – some possibly fundamental – in our 
ability to observe and perturb biological systems.
These observations imply that careful empirical assessment is essential to learn whether 
computational methods can provide causal insights in a specific biological setting of interest. 
Network inference methods are often assessed using data simulated from a known causal 
network structure (a so-called “gold-standard” network5,17). Such studies (and their 
synthetic biology counterparts21) are convenient and useful but at the same time limited 
because it is difficult to truly mimic the features of a specific biological system. Networks 
inferred from experimental data are often compared to the literature. However, since the goal 
of network inference is to learn novel regulatory relationships that could be specific to 
context, this is an inherently limited approach. Hypotheses generated by computational tools 
can be validated experimentally, but to date such assessment has been limited9,10,19,22.
Motivated by these observations, and with the support of the Heritage Provider Network 
(HPN), we developed the HPN-DREAM challenge to assess the ability to learn causal 
networks and predict molecular time-course data. The Dialogue for Reverse Engineering 
Assessment and Methods (DREAM) project23 (http://dreamchallenges.org) has run several 
challenges focused on network inference22,24–27. Here we focused on causal signaling 
networks in human cancer cell lines. Protein assays were carried out using reverse-phase 
protein lysate arrays28,29 (RPPA) that included functional phosphorylated proteins.
The HPN-DREAM challenge comprised three sub-challenges. Sub-challenge 1: Here, the 
task was to infer causal signaling networks using protein time-course data. To focus on 
networks specific to genetic and epigenetic background, the task spanned 32 different 
contexts, each defined by a combination of cell line and stimulus, and each with its own 
training and test data. The test data were used to assess the causal validity of inferred 
networks, as described below. A companion in silico data task also focused on causal 
networks but by design did not allow the use of known biology. Sub-challenge 2: 
Participants were tasked with predicting phosphoprotein time-course data under 
perturbation. The sub-challenge comprised both an experimental data task and an in silico 
data task and the same training datasets were used as in sub-challenge 1. Sub-challenge 3: 
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Participants were asked to develop methods to visualize these complex, multi-dimensional 
datasets.
In total across all sub-challenges, the scientific community contributed 178 submissions. In 
the network inference sub-challenge we found that several submissions achieved statistically 
significant results, providing substantive evidence that causal network inference may be 
feasible in a complex, mammalian setting (we discuss a number of relevant caveats below). 
The use of pre-existing biological knowledge (e.g. from online databases) appeared to be 
broadly beneficial. On the other hand, “FunChisq”, a method that did not incorporate any 
known biology whatsoever, was not only the top performer in the in silico data task, but also 
highly ranked in the experimental data task.
Challenge data, submissions and code are made available as a community resource through 
the Synapse platform30, which was used to run the challenge (https://www.synapse.org/
HPN_DREAM_Network_Challenge). Additionally, see Supplementary Notes 1–3 for 
descriptions of methods applied in the challenge.
Results
Training data for network inference
For the experimental data network inference task, participants were provided with RPPA 
phosphoprotein data from four breast cancer cell lines under eight ligand stimulus 
conditions. The 32 (cell line, stimulus) combinations each defined a biological context. Data 
for each context comprised time-courses for ~45 phosphoproteins (the set of 
phosphoproteins varied slightly between contexts; Supplementary Table 1). The training data 
included time-courses obtained under three kinase inhibitors and a control (DMSO, Fig. 2a; 
see Online Methods for details of experimental design, protocol, quality control and pre-
processing). The dataset is also available in an interactive online platform (http://
dream8.dibsbiotech.com) using the “Biowheel” design developed by the winning team of the 
visualization sub-challenge.
Participants were tasked with using the training data to learn causal networks specific to 
each of the 32 contexts. Networks had to comprise nodes corresponding to each 
phosphoprotein with directed edges between the nodes. The edges were required to have 
weights indicating strength of evidence in favor of each possible edge, but did not need to 
indicate sign (i.e. whether activating or inhibitory). For the companion in silico data task, 
participants were provided with data generated from a nonlinear differential equation model 
of signaling12. The task was designed to mirror some of the key features of the experimental 
setup and participants were asked to infer a single directed, weighted network (Online 
Methods; Supplementary Fig. 1). While the experimental data task tested both data-driven 
learning and use of known biology, the in silico data task focused exclusively on the former, 
and for that reason node labels (i.e. protein names in the underlying model) were 
anonymized.
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Empirical assessment of causal networks
Standard statistical assessments of goodness-of-fit or predictive ability are not suited to 
assessing causal network inference. This is due to the fact that an incorrect causal network 
can nonetheless score very well on such metrics (e.g. two nodes that are highly correlated 
but not causally linked (Fig. 1d) may predict each other well). We therefore developed a 
procedure that leveraged interventional data to assess the causal validity of networks 
submitted to the experimental data task. The key concept was to assess the extent to which 
causal relationships encoded in inferred networks were in agreement with test data obtained 
under an entirely unseen intervention (Fig. 2a). Specifically, for a given context c, we 
identified the set of nodes that showed salient changes under a test inhibitor (here, inhibition 
of mTOR) relative to DMSO control (Fig. 2b; Online Methods). These nodes are causally 
influenced by the inhibitor target (mTOR) and can be regarded as descendants of the target 
in the underlying causal network for context c. We denote this “gold-standard” descendant 
set by  (Supplementary Fig. 2; note that  may include both downstream nodes and 
those influenced via feedback loops within the experimental timeframe). For each submitted 
context-specific network, we computed a predicted set of descendants of mTOR, which we 
call . We then compared  to  to obtain an area under the receiver operating 
characteristic curve (AUROC) score (Fig. 2c) for each context c, resulting in a set of 32 
AUROC scores for each team. These were used to rank teams within each context. An 
overall score was obtained by computing the mean rank across contexts (see Online 
Methods) and this determined the final ranking (Fig. 2d, Table 1 and Supplementary Fig. 
3a). We tested robustness of the rankings using a subsampling strategy (see Online 
Methods). In Table 1 we include mean AUROC scores across the 32 contexts. Mean 
AUROC scores complement mean ranks by giving information on the absolute level of 
performance (the two metrics are highly correlated; see Supplementary Fig. 3c).
For the in silico data task, the true causal network was known (Online Methods; 
Supplementary Fig. 4) and this was used to obtain an AUROC score for each participant that 
determined the final rankings (Table 1 and Supplementary Fig. 3b).
An alternative scoring metric to AUROC is area under the precision-recall curve (AUPR), 
which is often used when there is an imbalance between the number of positives and 
negatives in the gold-standard31. Some of our gold-standard datasets were imbalanced and 
we therefore compared rankings based on AUROC and AUPR, finding reasonable 
agreement (Online Methods; Supplementary Figs. 5 and 6).
Performance of individual teams and ensemble networks
For the experimental data network inference task, Figure 3a shows the 32 AUROC scores for 
each team. 22 teams attained significant AUROC scores (FDR < 0.05; see Online Methods) 
in at least 25% of the contexts and 8 teams attained significant scores in at least 50% of 
contexts (Supplementary Fig. 7a). Conversely, for 25 out of the 32 contexts, 5 or more teams 
attained significant AUROC scores (Supplementary Fig. 7b). For the in silico data task, the 
top 14 teams achieved significant AUROC scores (Supplementary Fig. 3b). The fact that 
several teams achieved significant scores with respect to causal performance metrics 
suggests that causal network inference may be feasible in this setting.
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Scores on the experimental data and in silico data network inference tasks were modestly 
correlated (r = 0.35, p = 0.011), but better correlated when comparing only teams that did 
not use prior information (r = 0.68, p = 0.002; Fig. 3b and Supplementary Note 4). To 
identify teams that performed well across both tasks we calculated a combined ranking 
(average of ranks for experimental and in silico data tasks; Table 1, Fig. 3b and 
Supplementary Fig. 3d). Table 1 shows scores and method summaries for submissions 
ranked highly in either task or under the combined ranking; information for all teams can be 
found in Supplementary Table 2.
To test the notion of “crowdsourcing”22,27,32,33 for causal network inference, we combined 
inferred networks across all teams and assessed the resulting ensemble or aggregate 
submission (Online Methods; Fig. 3c and Supplementary Fig. 8a). For the experimental data 
task, the aggregate submission slightly outperformed the highest-ranked submission (mean 
AUROC of 0.80 and 0.78 respectively) and, for the in silico data task, it ranked within the 
top 5 (AUROC = 0.67). Combinations of as few as 25% of randomly chosen submissions 
performed well on average (mean AUROC of 0.72 and 0.64 for experimental and in silico 
data tasks respectively; Fig. 3d and Supplementary Fig. 8b).
A total of 41 of the 80 participating teams provided details about methods used 
(Supplementary Note 1) and we used this information to classify the submissions (Fig. 3e,f, 
Table 1 and Supplementary Note 5). In line with findings from previous DREAM 
challenges22,32, we observed no clear relationship between method class and performance. 
However, we note that the boundaries between method classes are not always well defined 
and that performance can be influenced by additional factors, including details of pre-
processing and implementation.
Top-performing methods for causal network inference
The best-scoring method for the experimental data task, "PropheticGranger with heat 
diffusion prior" by Team1, used a prior network created by averaging similarity matrices 
obtained via simulated heat diffusion applied to links derived from the Pathway Commons 
database34. This was then coupled with an L1-penalized regression approach that considered 
not only past but also future time points (see Supplementary Note 1 for a detailed 
description). The best scoring approach for the in silico data network inference task, and the 
most consistent performer across both data types, was the “FunChisq” method by Team7 
(see Supplementary Note 1). This approach used a novel functional chi-square test to 
examine functional dependencies among the variables and did not use any biological prior 
information. Before applying FunChisq, the abundance of each protein was discretized by 
the Ckmeans.1d.dp method35, with the number of discretization levels automatically 
selected using the Bayesian information criterion on a Gaussian mixture model.
Incorporating pre-existing biological knowledge
On average, teams that used prior biological information out-performed those that did not 
(Fig. 4a; one-sided rank-sum test, p = 0.032). The submission ranked second used only a 
prior network and did not use the protein data. However, use of a prior network did not 
guarantee good performance (mean AUROC scores ranged from 0.49 to 0.78 for teams 
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using a prior network). Interestingly, the same prior network that was itself ranked second 
was used in both the top-performing submission and the submission ranked 43rd, the 
difference being the approach used to analyze the experimental data. Conversely, not using a 
prior network did not necessarily result in poor performance (mean AUROC scores ranged 
from 0.49 to 0.71 for teams not using a prior network). The top-performing teams using 
prior networks in the experimental data task did not perform as well in the in silico data task 
(Fig. 3b).
To further investigate the influence of known biology, we combined submitted prior 
networks to form an aggregate prior network (Online Methods). This outperformed the 
individual prior networks and had a similar score to the aggregate submission described 
above (mean AUROC = 0.79). We combined the aggregate prior network with each of the 
two top methods (PropheticGranger and FunChisq) in varying proportions (Fig. 4b). 
Combining FunChisq with the aggregate prior improved upon the aggregate prior alone (this 
was not the case for PropheticGranger). Finally, we considered three-way combinations of 
PropheticGranger, FunChisq and the aggregate prior; the highest-scoring combination 
consisted of 20% PropheticGranger, 50% FunChisq and 30% aggregate prior (mean AUROC 
of 0.82, Supplementary Fig. 9). The combination weights were set by optimizing 
performance on the test data itself; we note that since additional test data were not available 
we cannot rigorously assess the combination analyses.
Context-specific performance
For the experimental data task, participants were required to infer networks specific to each 
context. The overall scoring metric is an average over all contexts; to gain additional insight 
we further investigated performance by context. Figure 4c shows, for each context, 
performance of the aggregate submission and aggregate prior, together with the top 25 
AUROC scores. In line with their good overall performance, the aggregates performed well 
relative to individual submissions in most contexts. The aggregate prior network performed 
particularly well for cell line MCF7, while in BT549 it performed less well for several 
stimuli. This supports the notion that biological contexts differ in the extent to which they 
agree with known biology. The aggregate submission offered the largest improvements over 
the aggregate prior in settings where the latter performed less well, suggesting that 
combining data-driven learning with known biology may offer the most utility in non-
canonical settings.
Crowdsourced context-specific signaling hypotheses
The context-specific aggregate submission networks provide crowdsourced signaling 
hypotheses; one such network is shown in Figure 5a. Comparing the aggregate submission 
networks with the aggregate prior network helps to highlight potentially novel edges: a list 
of context-specific edges with their associated scores is provided as a resource in 
Supplementary Table 3. Dimensionality reduction suggested that differences between cell 
lines are more prominent than between stimuli for a given cell line (Fig. 5b; Online 
Methods), in line with the notion that (epi)genetic background plays a key role in 
determining network architecture.
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Time-course prediction sub-challenge
Here, participants were tasked with predicting phosphoprotein time-courses obtained under 
interventions not seen in the training data (Online Methods). We assessed predictions by 
direct comparison with the test data using root mean squared error (RMSE; Online Methods 
and Supplementary Note 6). In contrast to the causal network inference sub-challenge, the 
focus was on predictive ability rather than causal validity. Submissions are summarized in 
Supplementary Table 4 and Supplementary Note 2. Testing robustness of team ranks gave 
two top-performers for the experimental data task and a single top-performer for the in silico 
data task (Online Methods;). The two top-performers for the experimental data task took 
different approaches. Team42 (ranked second) simply calculated averages of values in the 
training data. Team10 (ranked third) used a truncated singular value decomposition to 
estimate parameters in a regression model. This method also ranked highly for the in silico 
data task and was the most consistent performer across both data types. Team44, the top-
ranked team, was not eligible to be named as a top-performer (due to an incomplete 
submission; Supplementary Note 7), but their approach also consisted of calculating 
averages (the good performance of averaging may be explained to some degree by a 
shortcoming with the RMSE metric used here, see Supplementary Fig. 10). Team34, the top-
performer for the in silico data task, used a model informed by networks learned in the 
network inference sub-challenge. This suggests that network inference can also play a useful 
role in purely predictive analyses.
Visualization sub-challenge
In total, 14 teams submitted visualizations that were made available to the HPN-DREAM 
Consortium members who then voted for their favorite (Online Methods). The winning entry 
“Biowheel” is designed to enhance the visualization of time course protein data and aid in its 
interpretation (see Supplementary Note 3; http://dream8.dibsbiotech.com). The data 
associated with a cell line are plotted to depict protein abundance levels by color, as in a heat 
map, but displayed as a ring, or wheel. Time is plotted along the radial axis and increases 
from the center outwards. The interactive tool provides a way to mine data by displaying 
data subsets in various ways.
Discussion
Inferring molecular networks remains a key open problem in computational biology. This 
study was motivated by the view that empirical assessment will be essential in catalyzing the 
development of effective methods for causal network inference. Such methods will be 
needed to systemically link molecular networks to the phenotypes they influence. While 
there are many theoretical and practical reasons why causal network inference may fail, our 
results, obtained via a large-scale, community effort with blinded assessment, suggest that 
the task may be feasible in complex mammalian settings. By “feasible” we mean reaching a 
performance level significantly better than chance, and this was achieved by a number of 
submissions, including approaches that did not use any prior information. Nevertheless, our 
approach and findings are subject to caveats that we discuss below.
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We put forward an assessment approach that focuses on causal validity and is general 
enough to be potentially applicable in a variety of biological settings. However, it is 
important to take note of several caveats. First, the procedure relies on specificity of test 
inhibitors. However, if the inhibitor were highly non-specific, it would likely not be possible 
to achieve good results, nor for a prior network to perform well, because predictions 
themselves are based on assumed specificity. In addition, data suggest that the mTOR 
inhibitor used here does have good specificity. Second, the procedure used only one of the 
inhibitors for testing. Although not possible in a “live” challenge setting, as training and test 
data must be fixed at the outset, Hill, Nesser et al.36 used a cross-validation-type scheme that 
iterated over inhibitors. Such an approach may provide a more comprehensive assessment 
and indeed the ranking of methods could change when including additional inhibitors. Third, 
the procedure does not distinguish between direct and indirect causal effects. Finally, all 
downstream targets, whether context-specific or not, were weighted equally. Metrics that 
emphasize context-specific effects will be an important avenue for future research and would 
likely shed further light on the utility of priors (that are not usually context-specific).
Several submissions used novel methods or incorporated novel adaptations to existing 
methods (Supplementary Tables 2 and 4). Notably, the best performing team for the network 
inference in silico data task developed a novel procedure (FunChisq) that also performed 
well on the experimental data task without use of any prior information, increasing 
confidence in its robustness. Indeed, the ability to make such comparisons is a key benefit of 
running experimental and in silico challenges in parallel. Although some approaches 
performed well on one data type only (Fig. 3b), the overall positive correlation between 
experimental and in silico scores is striking given that they were based on different data and 
assessment metrics. Teams that did not use prior information were relatively well correlated 
(Fig. 3b), suggesting that good performers among these teams on the in silico data task could 
perform competitively on experimental data if extended to incorporate known biology.
The observation that prior information alone performs well reflects the fact that much is 
already known about signaling in cancer cells and suggests that causal networks are not 
entirely “re-wired” in these cells. On the other hand, our analysis revealed contexts which 
deviate from known biology; such deviations are likely particularly important for 
understanding disease-specific dysregulation and therapeutic heterogeneity. Furthermore, it 
is likely that the literature - and priors derived from it - is biased towards cancer and for that 
reason priors may be less effective in other disease settings. We anticipate that in the future a 
combination of known biology with data-driven learning will be important in elucidating 
networks in specific disease states.
A previous DREAM challenge also focused on signaling networks in cancer26. However, the 
scoring metric was predictive rather than causal (RMSE between predicted and test data 
points) with a penalty related to sparseness of the inferred network. Thus, the challenge did 
not focus on causal validity per se, and indeed a network with causally incorrect edges could 
yield a good RMSE score. Our assessment approach shares similarities with other 
approaches in the literature, including Maathuis et al.37 who focused on inferring networks 
from static observational data and Olsen et al.38 who used a different scoring metric, 
considering predicted downstream targets in close network proximity to the inhibited node.
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There are several directions that future challenges could take. The causal scoring approach 
proposed here could be applied in other settings, e.g. gene regulatory or metabolic networks. 
In the interests of open and transparent science, and to provide a community resource, 
participants were encouraged to make source code available. In order to facilitate post-
challenge analyses, future challenges may benefit from submission of executable programs 
that could allow for more controlled and detailed comparisons between methods.
It remains unclear to what extent the ranking of specific methods submitted to the challenge 
would generalize to different data-types and biological processes. In our view, it is still too 
early to say whether there could emerge broadly effective “out-of-the-box” methods for 
causal network inference, analogous to methods used for some machine learning tasks. Due 
to the complexity of causal learning and the many factors that could be application-specific 
we recommend that at the present time network inference efforts should whenever possible 
include at least some interventional data and that suitable scores, such as those described in 
this paper, should be used to assess network inference in a causal sense. Such an assessment 
would test whether inference is effective in the setting of interest.
Online Methods
Challenge data
The HPN-DREAM network inference challenge comprised three sub-challenges: causal 
network inference (SC1), time-course prediction (SC2) and visualization (SC3). Each of 
SC1 and SC2 consisted of two tasks, one based on experimental data (SC1A/SC2A) and the 
other based on in silico data (SC1B/SC2B).
Experimental data—The experimental data and associated components of the challenge 
are outlined in Figure 2a. Provided for the challenge were protein data from four breast 
cancer cell lines (UACC812, BT549, MCF7, BT20), All cell lines were acquired from 
ATCC, authenticated by STR analysis, and tested for mycoplasma contamination. The cell 
lines were chosen because they represent the major subtypes of breast cancer (basal, 
luminal, claudin-low, and HER2-amplified) and are known to have different genomic 
aberrations40–42. Each cell line sample was stimulated with 8 ligands (serum, PBS, EGF, 
Insulin, FGF1, HGF, NRG1, IGF1). We refer to each of the 32 possible combinations of cell 
line and stimulus as a biological context. For each context, data comprised time-courses for 
total proteins and post-translationally modified proteins, obtained under four different kinase 
inhibitors and a DMSO control. Full details of sample preparation, data generation, quality 
control, and pre-processing steps can be found in Hill, Nesser et al.36 and on the Synapse30 
webpages describing the challenge (https://www.synapse.org/
HPN_DREAM_Network_Challenge). In brief, cell lines were serum-starved for 24 hours 
and then treated for two hours with an inhibitor (or combination of inhibitors or DMSO 
vehicle alone). Cells were then either harvested (0 time point) or stimulated by one of the 
eight stimuli for 5, 15, 30, or 60 minutes, or 2, 4, 12, 24, 48, or 72 hours prior to protein 
harvest and analysis by reverse-phase protein array (RPPA) at MD Anderson Cancer Center 
Functional Proteomics Core Facility (Houston, Texas).
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RPPA is an antibody-based assay that provides quantitative measurements of protein 
abundance28,43. The MD Anderson RPPA core facility maintains and updates a standard 
antibody list on the basis of antibody quality control as well as a variety of other factors, 
including scientific interest. Antibodies available for use in this assay are therefore enriched 
for components of receptor tyrosine kinase (RTK) signaling networks and cancer-related 
proteins. For each cell line, we used the standard antibody list available at the time the 
assays were performed. 183 antibodies were used to target total (n = 132), cleaved (n = 3) 
and phosphoproteins (n = 48; Supplementary Table 1). As part of the RPPA pipeline, quality 
control was performed to identify slides with poor antibody staining. Antibodies with poor 
quality control scores were excluded from the dataset. During the challenge period, it 
became known to challenge organizers that several further antibodies were of poor quality. 
Participants were advised not to include the associated data in their analyses and these data 
were excluded from the scoring process. Measurements for each sample were corrected for 
protein loading and several outlier samples with large correction factors were identified and 
removed. The UACC812 data were split across two batches. A batch-normalization 
procedure was applied36 to enable the data from the two batches to be combined. The 
experimental data used in the challenge is a subset of the data reported in Hill, Nesser et 
al.36.
The inhibitors were chosen because they target key components of the RTK signaling 
cascades assessed by the RPPA assay and are also relevant to breast cancer. Participants 
were provided with a training dataset consisting of data for four out of the five inhibitor 
regimes (DMSO, PD173074 (FGFRi), GSK690693 (AKTi), GSK690693+GSK1120212 
(AKTi+MEKi)). Note that there was no training data available for the AKTi+MEKi inhibitor 
regime for cell lines BT549 (all stimuli) and BT20 (PBS and NRG1 stimuli). Data for the 
remaining inhibitor (AZD8055 (mTORi)) formed a test dataset, unseen by participants and 
used to evaluate submissions to the challenge.
The focus of the challenge was on short-term phosphoprotein signaling events and not on 
medium-to-long-term changes over hours and days (e.g. re-wiring of networks due to 
epigenetic changes arising from prolonged exposure to an inhibitor). Therefore the training 
data consisted only of phosphoprotein data (~45 phosphoproteins for each cell line) up to 
and including the four-hour time point; in the challenge this dataset was referred to as the 
“Main” dataset. In case some participants found the additional data useful, measurements for 
the remaining antibodies and time points were also made available in a “Full” dataset. The 
test data (and challenge scoring) also focused only on phosphoproteins up to and including 
the four-hour time point. At the time of the challenge all data were unpublished (the training 
dataset was made available to participants through the Synapse platform).
In silico data—The in silico data and associated components of the challenge are outlined 
in Supplementary Figure 1. Simulated data were generated from a nonlinear ordinary 
differential equation (ODE) model of the ERBB signaling pathway. Specifically, the model 
was an extended version of the mass action kinetics model developed by Chen et al.12. 
Training data were simulated for 20 network nodes (Supplementary Fig. 4; 14 
phosphoproteins, two phospholipids, GTP-bound RAS and three dummy nodes that were 
unconnected in the network) under two ligand stimuli (each at two concentrations; applied 
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individually and in combinations) and under three inhibitors targeting specific nodes in the 
network or no inhibitor. Mirroring the experimental data, inhibitors were applied prior to 
ligand stimulation at t=0. Time-courses consisted of 11 time points (0, 1, 2, 4, 6, 10, 15, 30, 
45, 60, 120 minutes) and three technical replicates were provided for each sample. A 
measurement error model was developed to reflect the antibody-based readout of RPPA 
assays and its technical variability. Node names were anonymized to prevent prior 
information being used to trivially reconstruct the network. Further details of the simulation 
model can be found in Supplementary Note 8.
An in silico test dataset was also generated to assess submissions to the time-course 
prediction sub-challenge and consisted of time-courses for each node and stimulus, under in 
silico inhibition of each network node in turn. After the final team rankings for the in silico 
data task were calculated, two minor issues concerning the in silico test data were 
discovered. The issues were corrected, test data were regenerated and final rankings and 
final leaderboards were updated. The top-performing teams remained unchanged by this 
update. See Supplementary Note 8 for further details.
Challenge questions and design
For the network inference sub-challenge experimental data task, participants were asked to 
use the training data to learn 32 signaling networks, one for each of the (cell line, stimulus) 
contexts. Networks had to contain nodes for each phosphoprotein in the training data (the 
node set therefore varied depending on cell line) and network edges had to be directed (but 
unsigned). The networks were expected to describe causal edges and this was reflected in 
the scoring (see below). A causal edge was defined as one where inhibition of the parent 
node can result in a change in the abundance of the child node that is not fully mediated via 
any other measured node (but the influence can take place via unmeasured nodes; Fig. 1). 
Participants were asked to submit confidence scores (between 0 and 1) for each possible 
directed edge in each network. Node names were not anonymized for the experimental data 
task and participants were allowed to use pre-existing biological information (e.g. from 
literature and online databases) in their analyses.
For the network inference sub-challenge in silico data task, participants were asked to infer a 
single network with 20 nodes (one for each variable in the training data) and directed edges 
corresponding to predicted causal relationships between the nodes. Submissions comprised a 
set of confidence scores for each possible directed edge in the network.
For the time-course prediction sub-challenge, participants were tasked with predicting time-
courses under interventions not contained in the training dataset. For the experimental data 
task, predictions were requested for five test kinase inhibitors (participants were informed of 
the inhibitor targets). For each inhibitor, time-courses consisting of seven time points (as in 
the training data) had to be predicted for each of the 32 contexts and for all phosphoproteins 
(except those targeted by the inhibitor). The in silico data task proceeded in an analogous 
fashion, with participants asked to predict time-courses under inhibition of each of the 20 
nodes in turn. Predicted time-courses were required for each node for each of the eight 
stimulus contexts.
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The visualization sub-challenge asked participants to devise novel approaches to represent 
the dataset provided with the challenge. The submission format was a schematic mock-up of 
the visualization.
The challenge was run over a period of three months. For the network inference and time-
course prediction sub-challenges participants were able to make submissions and obtain 
feedback via a leaderboard on a weekly basis (Supplementary Note 9). The frequency of 
feedback was chosen so as to obtain a balance between actively engaging participants and 
avoiding overfitting of models to the test data. To address this overfitting issue, other 
DREAM challenges33,44 used a second held-out test dataset for final scoring of submissions. 
However, this was not possible here due to the small number of inhibitor conditions in the 
data.
To incentivize participation, top-performing teams were awarded a modest cash prize 
(provided by the Heritage Provider Network), invitations to present results at a conference 
and co-author the paper describing the challenge, and (for SC1A only) the opportunity to 
have their method developed as a Cytoscape Cyni App39,45. See the Synapse pages 
describing the challenge (www.synapse.org/#!Synapse:syn1720047) and Supplementary 
Note 7 for further details.
Scoring procedure for the network inference sub-challenge experimental data task
Interventional test data—For the experimental data task, we developed a scoring 
procedure that used held-out interventional data to assess networks submitted by 
participants. The procedure assessed the extent to which causal relationships encoded in 
network submissions agreed with causal information contained in the test data. Using the 
held-out mTOR inhibitor data, we identified those phosphoproteins that showed a salient 
change in abundance under the inhibitor, relative to DMSO control (Fig. 2b). Specifically, let 
 and  denote the mean abundance levels of phosphoprotein i for (cell line, stimulus) 
context c under DMSO control and mTOR inhibition respectively (mean values calculated 
over 7 time points on log-transformed data; any replicates at each time point were averaged 
prior to taking the mean). A paired t-test was used to assess whether  is significantly 
different to , resulting in a p-value pi,c for each phosphoprotein and context.
Some phosphoproteins show a clear stimulus response under DMSO, characterized by a 
marked increase and subsequent decrease in abundance over time (a “peak” shape). In these 
cases, a change in abundance due to the mTOR inhibitor may be observable only at 
intermediate time points. Since the paired t-test described above considers all time points, 
the effect may be masked. Therefore we used a heuristic to detect phosphoproteins with a 
peak shaped time-course under DMSO and re-performed the paired t-test over the 
intermediate time points within the peak only. The resulting p-value was retained if smaller 
than the original. For each context, a test is performed for each phosphoprotein. We 
corrected for multiple testing within each context using the median adaptive linear step-up 
procedure46, resulting in q-values (FDR-adjusted p-values) qi,c. Note that due to the heuristic 
step, the q-values qi,c should not be interpreted formally.
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For each context, a phosphoprotein is determined to show a change under the mTOR 
inhibitor if the following two conditions are satisfied: (1) qi,c < 0.05 and (2) 
where σi,c is the pooled replicate standard deviation for the DMSO and mTOR inhibitor 
data. The second condition acts as a conservative filter to ensure effect sizes are not small 
relative to replicate variation. We work under the assumption that mTOR inhibition will lead 
to changes in abundance of all descendants of mTOR in the underlying context-specific 
causal network (i.e. changes are observed in any node for which a directed path exists from 
mTOR to that node; this can include downstream nodes as well as those that are influenced 
via feedback loops within the timescale of the experiments). Then, the above procedure 
results in context-specific “gold-standard” sets of causal descendants of mTOR 
 (Supplementary Fig. 2).
The scoring metric—For each context c, we compared the “gold-standard” descendant 
set  (obtained from the held-out test data) with predicted descendant sets obtained from 
context-specific networks submitted by participants (Fig. 2c). For context c, a submitted 
network consisted of edge confidence scores for each possible directed edge. Placing a 
threshold τ on edge scores resulted in a network structure consisting only of those edges 
with a score greater than τ and from this network we obtained a predicted set of descendants 
of mTOR (at threshold τ), denoted by . Comparing  with  gave the 
number of predicted descendants that are correct (true positives; TP(τ)) and the number of 
predicted descendants that are incorrect (false positives; FP(τ)). Varying the threshold τ and 
plotting TP(τ) against FP(τ) resulted in a receiver operating characteristic (ROC) curve and 
the scoring metric was the area under this curve (normalized to be between zero and one; 
AUROC). For each team AUROC scores were calculated for each of the 32 contexts.
The statistical significance of AUROC scores was determined using simulated null 
distributions, generated by calculating AUROC scores for 100,000 random networks, each 
consisting of random edge scores (drawn independently from the uniform distribution on the 
unit interval [0,1]). Gaussian fits to the null distributions were used to calculate p-values. For 
each context, the set of p-values (across all teams) underwent multiple testing correction 
using the Benjamini-Hochberg FDR procedure. There were two contexts (BT549, NRG1 
and BT20, insulin) for which no team achieved a statistically significant (FDR < 0.05) 
AUROC score (Supplementary Fig. 7b). These two contexts were therefore regarded as too 
challenging and were disregarded in the scoring procedure.
Teams were ranked within each context according to AUROC score. The resulting 30 rank 
scores for each team were then averaged to obtain a mean rank score. Final team rankings 
were obtained using mean rank scores (Fig. 2d).
During the challenge period, participants were informed only that submitted networks would 
be scored using test data obtained under interventions not present in the training data, but 
details of the scoring procedure and the identity, nature and number of interventions in the 
test data were not revealed. Note that participants knew identities of inhibitors in the training 
data.
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Gold-standard network and scoring metric for the network inference sub-challenge in 
silico data task
The true causal network underlying the variables in the in silico data was obtained from the 
data-generating nonlinear ODE model (Supplementary Fig. 4). However, deriving the causal 
network from the equations was non-trivial due to the model containing more variables than 
the 20 variables present in the challenge data and variables appearing in the model in 
complexes. Details of how the causal network was obtained can be found in Supplementary 
Note 8.
Each team submitted a single network consisting of a set of edge scores. This was compared 
directly to the gold-standard causal network to produce an ROC curve (by calculating the 
number of true positive and false positive edges at various edge score thresholds) and 
AUROC was used as the scoring metric. Self-edges were not considered for scoring. 
Statistical significance of AUROC scores was determined analogously to the experimental 
data task.
Alternative scoring metrics for the network inference sub-challenge
We used AUROC as the scoring metric for the network inference sub-challenge but we note 
that alternative metrics could have been used. In particular, the area under the precision-
recall curve (AUPR) is often used when there is an imbalance between the number of 
positives and negatives in the gold standard31. While many contexts in the experimental data 
task had a reasonable balance (median ratio of negatives to positives of 1.71), some contexts 
had many more negatives than positives and there was also an imbalance for the in silico 
data task (ratio of negatives to positives of 4.14; Supplementary Fig. 5). Therefore AUPR 
could have been an appropriate choice in several cases. For this reason, at the end of the 
challenge period we performed comparisons of final team rankings (obtained using 
AUROC) against rankings obtained using AUPR, or a combination of both AUROC and 
AUPR (Supplementary Fig. 6). For the experimental data task, the AUROC-based rankings 
showed good agreement with those obtained under either alternative metric. Agreement was 
not as strong for the in silico data task, but still reasonable with all metrics resulting in the 
same top performer. Furthermore, of the top ten teams under AUROC, only 2 are outside the 
top 10 under AUPR and they are ranked 12 and 13. Similarly, only 2 of the top 10 teams 
under AUPR are not in the top 10 under AUROC, and they are ranked 11 and 12. For 
openness and transparency, scores and rankings based on AUPR and the combination metric 
were included in the final leaderboards (available through Synapse: https://
www.synapse.org/HPN_DREAM_Network_Challenge; combination metric scores are also 
included in Supplementary Table 2).
Scoring metric for the time-course prediction sub-challenge
For both experimental data and in silico data, predictions of context-specific time-courses 
under inhibitors not contained in the training data were directly compared against context-
specific test data obtained under the corresponding inhibitor. Prediction accuracy was 
quantified using root mean squared error (RMSE) with comparisons made on log-
transformed data after averaging of replicates. RMSE scores were calculated separately for 
parts of the data that could potentially be on different scales. We refer to each portion of the 
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data where an RMSE score was calculated as a “data block”. Teams were ranked within each 
“data block” and a mean rank calculated to obtain a final ranking. Some blocks of data, 
where no team achieved a statistically significant score, were disregarded in the scoring 
procedure (Supplementary Tables 5 and 6; FDR < 0.05). Full details of scoring appear in 
Supplementary Note 6.
Visualization sub-challenge scoring
HPN-DREAM challenge participants scored submitted visualization proposals. 36 
participants cast votes by assigning ranks (from 1 to 3) to their three favorite submissions 
(the remaining submissions were all assigned a rank of 4). Teams were then ranked 
according to mean rank across the 36 votes (Supplementary Fig. 11).
Robustness of ranking under subsampling
To ensure team rankings were robust in the network inference and time-course prediction 
sub-challenges, we performed a subsampling analysis in which, for each of 100 iterations, 
50% of the test data were removed at random and rankings of submissions were recalculated 
using the remaining test data. Team A was considered to be robustly ranked above team B if 
the former outranked the latter in at least 75% of iterations.
For the network inference sub-challenge experimental data task, test data were subsampled 
by either (i) removing 50% of the phosphoproteins for each (cell line, stimulus) context 
when making comparisons between “gold-standard” and predicted descendant sets 
(Supplementary Fig. 12a), or (ii) by removing 50% of the contexts (i.e. scoring was based on 
15 contexts instead of 30; Supplementary Fig. 12b). The top team (Team1) outranked the 
team ranked second (Team2) in 76% and 97% of iterations for subsampling methods (i) and 
(ii) respectively. For the network inference sub-challenge in silico data task, 50% of the 
edges (and non-edges) in the gold-standard network were used for scoring (Supplementary 
Fig. 12c). The top scoring performer (Team7) had a higher AUROC score relative to the 
team ranked second (Team11) in 89% of the subsampling iterations.
For the experimental and in silico data tasks comprising the time-course prediction sub-
challenge, test data were subsampled by either (i) removing 50% of the “data blocks” (see 
above), or (ii) by subsampling 50% of the data points within each “data block”. For the 
experimental data task, the top-ranked team (Team44) outranked the team ranked second 
(Team42) in 90% and 54% of iterations for subsampling methods (i) and (ii) respectively. 
Due to the 75% threshold not being met for one of the subsampling methods, Team44 was 
not regarded as being ranked robustly above Team42. Team42 outranked the team ranked 
third (Team10) in 60% and 70% of iterations and so, again, the ranking was not regarded as 
robust. However, Team10 was robustly ranked above the team ranked fourth (93% and 94% 
of iterations). Team44 was not eligible to be named as a top-performer due to an incomplete 
submission (Supplementary Note 7) and so the teams ranked second and third (Team42 and 
Team10) were named as top-performers. For the in silico data task, the top team (Team34) 
outranked the team ranked second in 95% and 100% of iterations for subsampling methods 
(i) and (ii) respectively.
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Crowdsourced analyses: aggregate submission networks and aggregate prior network
Aggregate submission networks were obtained by integrating predicted networks across all 
teams (to avoid bias, a filtering process was used to remove correlated submissions from the 
aggregation; 66 and 57 teams formed the aggregate networks for the experimental and in 
silico data tasks respectively; Supplementary Note 10 and Supplementary Table 2). For the 
experimental data task, an aggregate network was formed for each of the 32 contexts. Each 
aggregate submission network consisted of a set of edge scores, calculated by taking the 
mean of scores submitted by teams for each edge. To ensure edge scores were comparable 
across teams, scores for each team were scaled prior to aggregation so that the maximum 
edge score (across all 32 contexts for the experimental data task) had a value of one.
For the experimental data task, an aggregate prior network was formed in an analogous 
manner to the aggregate submission networks, using 10 prior networks provided by teams 
(the prior network submitted by Team2 was also used by several other teams, but was only 
included once in the aggregation; Supplementary Table 2). Individual prior networks and 
therefore the aggregate prior network were not context-specific.
Principal component analysis (PCA) of context-specific aggregate submission networks
The 32 context-specific aggregate submission networks for the network inference sub-
challenge experimental data task were combined into a matrix E of edge scores where 
columns correspond to contexts and rows correspond to edges (only network nodes common 
to all contexts were considered for this analysis). Each row of matrix E contains the scores 
for a specific edge in each of the contexts. PCA was performed on this matrix using the 
MATLAB function princomp.
Web-based community resource
A community resource has been made available through the Synapse platform at https://
www.synapse.org/HPN_DREAM_Network_Challenge, under the section titled “HPN-
DREAM Community Resource”. This resource includes: all challenge data, participant 
submissions, participant code, participant prior networks and crowdsourced aggregate 
networks. Code for scoring submissions is available as part of the DREAMTools software 
package47 (Supplementary Note 11).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Causal networks. The network inference sub-challenge focused on causal relationships 
between nodes. (a) A directed edge (or link) in a causal network carries the interpretation 
that inhibition of the parent node (A) can change abundance of the child node (B) (the 
change could be up or down, here the latter is shown). (b) Causal edges, as used here, may 
represent direct effects or indirect effects that occur via unmeasured intermediate nodes. If 
node A causally influences node B via a measured node C, the causal network should 
contain edges from A to C and C to B, but no edge from A to B (top). However, if node C 
were not measured (and not part of the network), the causal network should contain an edge 
from A to B (bottom). Note that in both these cases inhibition of node A would lead to a 
change in node B. (c) Causal edges may depend on biological context. In the example 
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shown, there is a causal edge from A to B in Context 1, but not in Context 2 (line colors are 
as in a). (d) Correlation and causation. In the example shown, nodes A and B are correlated 
due to regulation by the same node (C). However, in this example no sequence of 
mechanistic events links A to B, and thus inhibition of A does not change the abundance of 
B (line colors are as in a). Therefore, despite the correlation, there is no causal edge from A 
to B.
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Figure 2. 
The HPN-DREAM network inference challenge: overview of experimental data tasks and 
causal assessment strategy. (a) Protein data were obtained from four cancer cell lines under 
eight ligand stimuli (data as described in Hill, Nesser et al.36). For each of the 32 resulting 
contexts, participants were provided training data comprising time-courses for ~45 
phosphoproteins under three different kinase inhibitors and a control (DMSO). The sub-
challenge 1 experimental data task (SC1A) asked participants to infer signaling networks 
specific to each context. In SC2A the aim was to predict context-specific molecular time-
courses. In both cases, submissions were assessed using held-out, context-specific test data 
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that were obtained under an unseen intervention (inhibition of the kinase mTOR). Each sub-
challenge also comprised a companion in silico data task (SC1B/SC2B; text, Online 
Methods and Supplementary Fig. 1). (b) Networks submitted to the experimental data task 
(SC1A) were assessed causally in terms of agreement with the interventional test data. For 
each context, the set of nodes that changed under mTOR inhibition was identified (“gold-
standard” causal descendants of mTOR; see text and Online Methods). In the example 
shown, node X is a descendant of mTOR while Y is not. (c) In submitted, context-specific 
networks, predicted descendants of mTOR were identified and compared with their 
experimentally-determined “gold-standard” counterparts. This gave true and false positive 
counts and a (context-specific) AUROC (area under the receiver operating characteristic 
curve). (d) In each context, teams were ranked by AUROC score and mean rank across 
contexts gave the final rankings (Table 1).
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Figure 3. 
Network inference sub-challenge (SC1) results. (a) Heatmap showing assessment scores 
(AUROC) in each of the 32 (cell line, stimulus) contexts for the 74 teams that made 
submissions to the experimental data task (teams ordered by final ranking). (b) Scatter plot 
comparing scores in experimental and in silico data tasks. Each square represents a team, 
with color indicating whether prior information was used for the experimental data task and 
red border indicating that a different method was used in each task. Numerical annotation 
indicates ranks for the top ten teams under a combined score (see text; three teams were 
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jointly ranked third under this score). (c,d) Results of crowdsourcing for the experimental 
data task. Aggregate submission networks were formed by combining, for each context, 
networks from top scoring (c) or randomly selected (d) teams (Online Methods). Blue line 
shows performance of the aggregate submission versus number of teams aggregated, with 
red circles depicting individual team scores. Dashed black line indicates the result of 
aggregating all submissions. Results in d are mean values over 100 iterations of random 
selection (error bars indicate s.d.). See Supplementary Figure 8 for analysis of the in silico 
data task. (e,f) Performance by method type for the experimental (e) and in silico (f) data 
tasks. Final rank appears above each bar and the gray line shows mean performance of 
random predictions. Note that some teams used a different approach for each task or only 
participated in a single task (Supplementary Table 2).
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Figure 4. 
Network inference sub-challenge experimental data task (SC1A): role of prior information. 
(a) Tukey-style box plots over mean AUROC scores for teams that did/did not use a prior 
network. P-value calculated by a Wilcoxon rank-sum test (n = 18). (b) An aggregate prior 
network (text and Online Methods) was combined with networks inferred by two top-
performing methods: (i) the “PropheticGranger” approach (top performer in SC1A when 
combined with a network prior) and (ii) the “FunChisq” approach (top performer in SC1B). 
Horizontal axis indicates relative contribution of the aggregate prior (zero indicates no 
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contribution and one indicates aggregate prior alone) and the vertical axis is the score of the 
resulting networks. The blue line indicates performance when combining the aggregate prior 
with randomly generated networks (mean performance over 30 random networks shown, 
with shaded region indicating standard deviation). The dashed black line shows the mean 
AUROC score achieved by the top-performing team in the experimental data task. Error bars 
indicate s.e.m. (c) Top: Tukey-style box plots over AUROC scores for the top 25 performers 
for each context. The green triangles and purple circles indicate performance of the 
aggregate submission and the aggregate prior respectively. Bottom: Receiver operating 
characteristic (ROC) curves for two contexts where a difference in performace was observed 
between the aggregate submission and aggregate prior.
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Figure 5. 
Aggregate submission networks for the network inference experimental data task (SC1A). 
(a) Aggregating all submissions gave a network for each of 32 (cell line, stimulus) contexts; 
the network for cell line MCF7 under HGF stimulus is shown. Line thickness corresponds to 
edge weights (number of edges shown set to equal number of nodes). Black solid (red 
dashed) lines indicate edges that are present (not present) in the aggregate prior network 
(obtained by placing a threshold of 0.1 on edge weights). Green/blue nodes are descendants 
of mTOR in the network shown; green nodes are true positives with respect to the test data 
while blue nodes are false positives (Figs. 2b,c and Supplementary Fig. 2). Network 
generated using Cytoscape39. (b) Principal components analysis (PCA) was applied to the 
context-specific aggregate submission networks (Online Methods) with the 32 contexts 
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colored by cell line (PCA was applied to vectors comprising edge scores for the 32 
aggregate networks).
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